STOCK TITAN

Conexeu Sciences sets Jan. 26, 2027 special meeting

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Conexeu Sciences Inc. (CNXU) filed a notice for a special stockholders’ meeting scheduled for January 26, 2027, in Vancouver, British Columbia. December 8, 2026, is the record date for notice and voting and the beneficial ownership determination date. Notice-and-access applies to registered and beneficial holders. Conexeu will pay for delivery of materials to OBOs and will not send materials directly to NOBOs.

Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Special meeting date January 26, 2027 Conexeu Sciences Inc. special meeting of stockholders
Record date December 8, 2026 Applies to notice, voting and beneficial ownership determination
National Instrument 54-101 regulatory
"in accordance with ... National Instrument 54-101"
A Canadian securities rule that sets how companies and their intermediaries must communicate with investors who hold shares through brokers or banks, ensuring those ‘beneficial owners’ reliably receive annual reports, proxy materials and voting information. It matters to investors because it determines how and when you get important paperwork and voting rights—like setting a reliable mail system so shareholders don’t miss meetings or lose the ability to vote on company decisions.
Notice-and-Access technical
"Notice-and-Access for Registered Holders: Yes"
A notice-and-access delivery model sends shareholders a short notice telling them where to find full proxy materials and other corporate documents online instead of receiving bulky paper copies by mail. For investors it matters because it speeds delivery and cuts costs for companies, but also shifts responsibility onto shareholders to retrieve and read the materials before voting or making decisions—like getting a postcard with a link to the full report rather than the report itself.
NOBOs technical
"Company sending materials directly to NOBOs: No"
OBOs technical
"Company to pay for delivery of materials to OBOs: Yes"
Beneficial Ownership Determination Date regulatory
"Beneficial Ownership Determination Date: December 8, 2026"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

false 2026-11-10 0002066836 Conexeu Sciences Inc. 0002066836 2026-11-10 2026-11-10

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 10, 2026

CONEXEU SCIENCES INC.
(Exact name of registrant as specified in its charter)

Nevada 001-43283 33-4814282
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)

50 West Liberty Street, Suite 880,
Reno, Nevada, United States 89501
(Address of principal executive offices) (ZIP Code)

Registrant's telephone number, including area code: (424) 333-5622

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class   Trading Symbols   Name of each exchange on which registered
Common Stock   CNXU   The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b -2 of this chapter).

Emerging growth company ☑

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


SECTION 8 - OTHER EVENTS

Item 8.01 Other Events

On November 10, 2026, Conexeu Sciences Inc. (the "Company") filed a Notice of Meeting and Record Date for its Special Meeting of Stockholders to be held on January 26, 2027 on the System for Electronic Document Analysis and Retrieval with the British Columbia Securities Commission in Canada in accordance with the requirements of the Canadian Securities Administrators National Instrument 54-101 - Communication with Beneficial Owners of Securities of a Reporting Issuer as the Company is a reporting issuer in British Columbia, Canada.

A copy of the Notice of Meeting and Record Date is filed as Exhibit 99.1 hereto.

SECTION 9 - FINANCIAL STATEMENTS AND EXHIBITS

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

Exhibit
Description
99.1   Notice of Meeting and Record Date
104   Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  CONEXEU SCIENCES INC.
 
DATE:  November 16, 2026 By: /s/ Stephen Inouye
Stephen Inouye
CFO, Secretary and Treasurer
 


CONEXEU SCIENCES INC.

November 10, 2026

All Canadian Securities Regulatory Authorities

Dear Sirs:

Re: Special Meeting of Conexeu Sciences Inc.

Conexeu Sciences Inc., a Nevada corporation, whose common stock is registered under section 12(b) of the United States Securities Exchange Act of 1934, as amended, advises of the following with respect to the upcoming meeting of security holders:

Company: Conexeu Sciences Inc.
Meeting Type: Special Meeting
CUSIP#:   
ISIN#: 
20715F100
US20715F1003
Class of Security entitled to receive Notice: Common
Class of Security entitled to vote at Meeting: Common
Record Date for Notice: December 8, 2026
Record Date for Voting: December 8, 2026
Beneficial Ownership Determination Date: December 8, 2026
Meeting Date: January 26, 2027
Place of Meeting: Suite 1500, 1055 West Georgia Street, Vancouver, British Columbia, Canada
Company sending materials directly to NOBOs: No
Company to pay for delivery of materials to OBOs: Yes
Notice-and-Access for Registered Holders: Yes
Notice and Access for Beneficial Holders: Yes

If you require further information, please contact the undersigned.

Yours truly,

CONEXEU SCIENCES INC.

Per "Stephen Inouye"

Stephen Inouye,
Chief Financial Officer


Filing Exhibits & Attachments

6 documents

Keep reading